Subramanian S - Search Results

1

Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Chetwood JD, Tran Y, Subramanian S, Smith PJ, Iborra M, Buisson A, Paramsothy S, Leong RW. Chetwood JD, et al. Among authors: subramanian s. J Crohns Colitis. 2024 Sep 3;18(9):1440-1449. doi: 10.1093/ecco-jcc/jjae059. J Crohns Colitis. 2024. PMID: 38656784

2

IBD Risk-It Is All in the Family!

Sharip MT, Subramanian S. Sharip MT, et al. Among authors: subramanian s. J Crohns Colitis. 2023 Jan 27;17(1):28-29. doi: 10.1093/ecco-jcc/jjac118. J Crohns Colitis. 2023. PMID: 36048169 No abstract available.

3

Inflammatory bowel disease in 2024 and beyond.

Gearry RB, Seow CH, Subramanian S. Gearry RB, et al. Among authors: subramanian s. Aliment Pharmacol Ther. 2024 Nov;60(9):1164-1165. doi: 10.1111/apt.18295. Aliment Pharmacol Ther. 2024. PMID: 39403063 No abstract available.

4

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.

Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.

5

Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetings.

Sayers S, Lam D, Shah Q, Evans J, Parkes M, Stober C, Rimmer J, Clunie G, Gudu TE, Rosembert D, Subramanian S, Brookes-Jones S, Moss S, Raine T, Jadon D. Sayers S, et al. Among authors: subramanian s. Rheumatology (Oxford). 2024 Feb 23:keae116. doi: 10.1093/rheumatology/keae116. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38391112

6

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.

Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR. Subramanian S, et al. Inflamm Bowel Dis. 2011 Jan;17(1):99-104. doi: 10.1002/ibd.21370. Inflamm Bowel Dis. 2011. PMID: 20629183 Clinical Trial.

7

Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy.

Kushner T, Fairchild A, Johnson FR, Sands BE, Mahadevan U, Subramanian S, Ananthakrishnan A, Ha C, Bewtra M. Kushner T, et al. Among authors: subramanian s. Patient. 2022 May;15(3):353-365. doi: 10.1007/s40271-021-00561-9. Epub 2021 Nov 9. Patient. 2022. PMID: 34750784

8

The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis.

Pillay L, Subramanian S. Pillay L, et al. Among authors: subramanian s. Inflamm Bowel Dis. 2024 Nov 4;30(11):2238-2239. doi: 10.1093/ibd/izae025. Inflamm Bowel Dis. 2024. PMID: 38452032 No abstract available.

9

Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease-Perception and Reality.

Kuriakose Kuzhiyanjal AJ, Subramanian S, Limdi JK. Kuriakose Kuzhiyanjal AJ, et al. Among authors: subramanian s. Dig Dis Sci. 2025 Jan 22. doi: 10.1007/s10620-025-08855-w. Online ahead of print. Dig Dis Sci. 2025. PMID: 39843791 No abstract available.

10

Effect of yogic breathing practice on all-round well-being of teenagers.

Subramanian S, Saisudha B, Kanchibhotla D. Subramanian S, et al. Clin Child Psychol Psychiatry. 2025 Jan 20:13591045251315210. doi: 10.1177/13591045251315210. Online ahead of print. Clin Child Psychol Psychiatry. 2025. PMID: 39829376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,429 results

Search Page

Filters